NJ A3525 | 2018-2019 | Regular Session
Note: Carry Foward to future A3603
Note: Carry Foward to future S2212
Note: Carry Over of previous A4347
Note: Carry Foward to future S2212
Note: Carry Over of previous A4347
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 5 2018 - 25% progression, died in committee
Action: 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on March 5 2018 - 25% progression, died in committee
Action: 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
"Prescription Drug Consumer Transparency Act."
Title
"Prescription Drug Consumer Transparency Act."
Sponsors
History
Date | Chamber | Action |
---|---|---|
2018-03-05 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A3525 (Carry Over) 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A3525 (Carry Over) 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A4347 (Carry Over) 2016-12-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A3525 (Carry Over) 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A4347 (Carry Over) 2016-12-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2018/A3525 |
Text | https://pub.njleg.gov/Bills/2018/A4000/3525_I1.HTM |